40 Participants Needed

Cognitive Training + Brain Stimulation for Alcoholism

HV
JC
CB
Overseen ByClarista Berg
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial aims to help people with alcohol use disorder by using a gentle electrical brain stimulation combined with mental exercises. The goal is to improve their ability to stay sober for a long time. Researchers will also study how genetic differences affect treatment success.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have a stable psychiatric disorder that is being treated, you can still participate.

What data supports the effectiveness of the treatment Cognitive Training + Brain Stimulation for Alcoholism?

Research shows that combining brain stimulation (tDCS) with cognitive training can improve brain function in people with alcohol-related brain issues. This combination has been effective in enhancing cognitive abilities in other conditions, suggesting it might help with alcoholism too.12345

Is transcranial direct current stimulation (tDCS) safe for humans?

Research suggests that transcranial direct current stimulation (tDCS) is generally safe for humans, as it has been used in studies with healthy individuals and patients with neurocognitive disorders without major safety concerns. However, some studies have shown mixed results regarding its effectiveness, and it may not always improve cognitive functions as expected.56789

How does the Cognitive Training + Brain Stimulation treatment for alcoholism differ from other treatments?

This treatment combines cognitive training, which involves exercises to improve thinking skills, with transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique. Unlike traditional treatments, this approach targets brain function directly to enhance executive functions and reduce alcohol cravings, potentially leading to fewer relapses.1251011

Research Team

JC

Jazmin Camchong, PhD

Principal Investigator

Univeristy of Minnesota Department of Psychiatry & Behavioral Sciences

Eligibility Criteria

This trial is for individuals with Alcohol Use Disorder (AUD) who are committed to staying in a treatment program and have been abstinent from alcohol. They must meet specific mental health criteria, not have other primary substance use disorders except caffeine or nicotine, and cannot have certain neurological conditions or contraindications for tDCS or MRI.

Inclusion Criteria

I plan to stay in the Lodging Plus program for the study's duration.
Meet the Diagnostic and Statistical Manual of Mental Disorders diagnostic criteria for AUD
Abstinent from alcohol use

Exclusion Criteria

I have been diagnosed with Wernicke-Korsakoff syndrome.
Presence of a condition that would render study measures difficult or impossible to administer or interpret
Primary current substance use disorder diagnosis on a substance other than alcohol except for caffeine or nicotine
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 5 sessions of tDCS while in the Lodging Plus treatment program and 5 remote sessions after discharge, with cognitive training tasks and MRI sessions

2 weeks
5 in-person sessions, 5 remote sessions

Follow-up

Participants are monitored for relapse status and cognitive performance monthly for 4 months post-intervention

4 months
Monthly follow-up interviews

Treatment Details

Interventions

  • Executive Function Focused Cognitive Training
  • TaskFlow Transcranial Electrical Stimulation device
Trial Overview The TANGO study tests if combining brain stimulation (tDCS) targeting the DLPFC region with cognitive training can improve executive function and help maintain abstinence in AUD patients. It also explores how genetic profiles might influence treatment response.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Participants receiving active transcranial direct current stimulation (tDCS)Experimental Treatment2 Interventions
Participants in this group will receive 5 sessions of active transcranial direct current stimulation (tDCS) to dorsolateral prefrontal cortex (DLPFC) while in the Lodging Plus treatment program and then 5 remote sessions of active tDCS to DLPFC after discharge from the treatment program. All participants will engage in executive functioning tasks for cognitive training during tDCS intervention (active or sham) to prime the engagement of the nucleus accumbens prefrontal cortex circuit. All participants will complete 4 MRI sessions. Craving measures will be collected before the first and after the last day of tDCS sessions. Follow-up interviews will be conducted monthly during a 4-month follow-up period after intervention completion to query relapse status. The first two follow-up interviews, at approximately 1- and 2-months post-intervention, will also include collection of cognition data.
Group II: Participants receiving active and sham active transcranial direct current stimulation (tDCS)Placebo Group2 Interventions
Participants in this group will receive 5 sessions of sham-tDCS sessions while in the Lodging Plus treatment program and then 5 remote sessions of active-tDCS to DLPFC after discharge from the treatment program. All participants will engage in executive functioning tasks for cognitive training during tDCS intervention (active or sham) to prime the engagement of the nucleus accumbens prefrontal cortex circuit. All participants will complete 4 MRI sessions. Craving measures will be collected before the first and after the last day of tDCS sessions. Follow-up interviews will be conducted monthly during a 4-month follow-up period after intervention completion to query relapse status. The first two follow-up interviews, at approximately 1- and 2-months post-intervention, will also include collection of cognition data.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

The study involving 44 children with Fetal Alcohol Spectrum Disorders (FASD) found that transcranial direct current stimulation (tDCS) combined with cognitive training (CT) was feasible and well-tolerated, showing nominal improvements in attention compared to a sham treatment.
While tDCS-augmented CT did not significantly enhance working memory or other cognitive tasks, improvements in attention were correlated with reduced parent-reported attention deficits, suggesting potential benefits of this combined approach for children with FASD.
A randomized controlled trial of transcranial direct-current stimulation and cognitive training in children with fetal alcohol spectrum disorder.Boroda, E., Krueger, AM., Bansal, P., et al.[2020]
Cranial electrotherapy stimulation (CES) was found to significantly improve brain dysfunction in alcoholic patients, particularly on two subscales of the Revised Beta Examination that are linked to brain health.
CES may reduce the recovery time for reversible brain dysfunctions in alcoholics from months or years to just weeks, suggesting it could be a valuable treatment option for enhancing recovery.
Confirming evidence of an effective treatment for brain dysfunction in alcoholic patients.Smith, RB.[2019]
Transcranial direct current stimulation (tDCS) applied to the left dorsolateral prefrontal cortex significantly increased P3 amplitude in response to alcohol-related sounds in 49 alcoholic subjects, indicating enhanced frontal lobe activity, particularly in those classified as Lesch IV alcoholics.
Active tDCS also led to notable improvements in cognitive performance on the Frontal Assessment Battery (FAB) specifically for Lesch IV alcoholics, suggesting potential clinical benefits in addressing frontal dysfunction associated with alcohol dependence.
Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology.Nakamura-Palacios, EM., de Almeida Benevides, MC., da Penha Zago-Gomes, M., et al.[2022]

References

A randomized controlled trial of transcranial direct-current stimulation and cognitive training in children with fetal alcohol spectrum disorder. [2020]
Confirming evidence of an effective treatment for brain dysfunction in alcoholic patients. [2019]
Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology. [2022]
BRAINSTORMING: A study protocol for a randomised double-blind clinical trial to assess the impact of concurrent brain stimulation (tDCS) and working memory training on cognitive performance in Acquired Brain Injury (ABI). [2021]
Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. [2020]
"Unfocus" on foc.us: commercial tDCS headset impairs working memory. [2022]
Modulation of Repeated Anodal HD-tDCS on Attention in Healthy Young Adults. [2020]
Safety and Feasibility of Transcranial Direct Current Stimulation for Cognitive Rehabilitation in Patients With Mild or Major Neurocognitive Disorders: A Randomized Sham-Controlled Pilot Study. [2022]
Effects of prefrontal tDCS on executive function: Methodological considerations revealed by meta-analysis. [2019]
Multiple Sessions of Transcranial Direct Current Stimulation (tDCS) Reduced Craving and Relapses for Alcohol Use: A Randomized Placebo-Controlled Trial in Alcohol Use Disorder. [2020]
11.Korea (South)pubmed.ncbi.nlm.nih.gov
Improved Executive Functions and Reduced Craving in Youths with Methamphetamine Addiction: Evidence from Combined Transcranial Direct Current Stimulation with Mindfulness Treatment. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity